Suppressive and Hypermethylated MicroRNAs in the Pathogenesis of Breast Cancer
В. И. Логинов(Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences), Э. А. Брага(Research Centre for Medical Genetics), Е. А. Филиппова, A. M. Burdennyy(Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences), М. В. Фридман(New York University), С. В. Куревлев(Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences)
Cited by 3
Related Papers
In vivo measurement of afferent activity with axon-specific calcium imaging
|Nature Neuroscience|2018|249
LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms
|International Journal of Molecular Sciences|2020|230
Landscape of allele-specific transcription factor binding in the human genome
|Nature Communications|2021|204
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein–Overexpressing Advanced Nonsquamous <i>EGFR</i> -Wildtype Non–Small Cell Lung Cancer in the Phase II LUMINOSITY Trial
|Journal of Clinical Oncology|2024|131
Molecular mechanisms and microRNAs in osteosarcoma pathogenesis
|Biochemistry (Moscow)|2016|121